Artivion Financials

AORT Stock  USD 24.08  0.04  0.17%   
Based on the analysis of Artivion's profitability, liquidity, and operating efficiency, Artivion may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Artivion's Non Currrent Assets Other are comparatively stable compared to the past year. Net Receivables is likely to gain to about 90.2 M in 2025, despite the fact that Retained Earnings are likely to grow to (58.2 M). Key indicators impacting Artivion's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.02790.0294
Notably Down
Slightly volatile
Current Ratio3.484.341
Significantly Down
Pretty Stable
Investors should never underestimate Artivion's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Artivion's cash flow, debt, and profitability to make informed and accurate decisions about investing in Artivion.

Net Income

(12.69 Million)

  
Understanding current and past Artivion Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Artivion's financial statements are interrelated, with each one affecting the others. For example, an increase in Artivion's assets may result in an increase in income on the income statement.

Artivion Earnings Geography

Please note, the imprecision that can be found in Artivion's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Artivion. Check Artivion's Beneish M Score to see the likelihood of Artivion's management manipulating its earnings.

Artivion Stock Summary

Artivion competes with Anika Therapeutics, Sight Sciences, Orthofix Medical, Avanos Medical, and Axogen. Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company was founded in 1984 and is headquartered in Kennesaw, Georgia. Artivion operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1300 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS2289031005
CUSIP228903100
LocationGeorgia; U.S.A
Business Address1655 Roberts Boulevard
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteartivion.com
Phone(770) 419 3355
CurrencyUSD - US Dollar

Artivion Key Financial Ratios

Artivion Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets789.4M793.1M762.8M792.4M789.1M828.6M
Other Current Liab34.1M21.9M25.8M35.3M40.6M42.7M
Net Debt255.4M307.0M317.5M299.4M8.1M7.7M
Retained Earnings20.0M2.0M(17.2M)(47.9M)(61.3M)(58.2M)
Accounts Payable9.6M10.4M12.0M13.3M18.0M18.9M
Cash62.0M55.0M39.4M58.9M53.5M56.1M
Net Receivables48.8M58.1M69.6M74.1M85.9M90.2M
Other Current Assets51.4M57.6M63.9M65.6M71.0M74.5M
Total Liab460.7M492.3M478.5M510.6M512.9M538.5M
Total Current Assets234.6M247.7M247.3M280.7M290.1M304.6M
Short Term Debt13.9M9.0M9.3M5.4M5.3M6.8M
Intangible Assets227.1M201.5M182.6M172.2M156.4M164.2M
Inventory73.0M77.0M74.5M82.0M79.8M83.8M
Common Stock404K414K418K426K434K335.4K
Good Will260.1M250M243.6M247.3M241.0M151.9M
Other Liab36.9M90.4M90.6M77.4M89.0M69.6M
Net Tangible Assets(58.7M)(158.4M)(150.8M)(141.9M)(127.8M)(134.1M)
Other Assets19.7M16.0M10.6M8.7M7.8M10.2M
Long Term Debt290.5M307.5M306.5M305.5M314.2M307.1M
Net Invested Capital620.4M609.9M592.4M588.8M590.5M627.8M
Short Long Term Debt1.2M1.6M1.6M1.5M195K185.3K
Capital Stock404K414K418K426K434K451.2K
Net Working Capital174.1M202.7M197.7M222.8M223.3M205.5M

Artivion Key Income Statement Accounts

The reason investors look at the income statement is to determine what Artivion's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Total Revenue253.2M298.8M313.8M354.0M388.5M408.0M
Gross Profit167.8M197.5M202.5M229.2M248.8M261.2M
Operating Income2.4M(13.9M)3.2M5.7M38.9M40.8M
Ebit(7.6M)1.1M(2.7M)3.8M26.8M28.1M
Ebitda20.2M25.0M19.7M26.9M51.0M53.5M
Cost Of Revenue85.4M101.3M111.3M124.8M139.8M146.7M
Income Before Tax(17.2M)(14.8M)(15.0M)(21.6M)(7.5M)(7.1M)
Net Income(16.7M)(14.8M)(19.2M)(30.7M)(13.4M)(12.7M)
Income Tax Expense(492K)7K4.2M9.1M5.8M6.1M
Research Development24.2M35.5M38.9M28.7M28.5M29.9M
Interest Expense16.7M16.9M18.2M25.3M34.3M36.0M
Tax Provision(492K)7K4.2M6.8M5.8M6.1M
Net Interest Income(16.5M)(16.8M)(18.1M)(23.7M)(32.8M)(31.2M)
Interest Income217K79K147K740K1.5M1.5M

Artivion Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash27.7M(6.9M)(15.7M)19.6M(5.5M)(5.2M)
Free Cash Flow5.0M(15.7M)(15.9M)11.4M11.0M11.6M
Depreciation20.7M24.0M22.4M23.1M24.2M25.4M
Other Non Cash Items23.8M15.3M6.9M29.6M(1.3M)(1.3M)
Capital Expenditures7.3M13.1M10.7M7.4M11.2M11.7M
Net Income(16.7M)(14.8M)(19.2M)(30.7M)(13.4M)(12.7M)
End Period Cash Flow62.0M55.0M39.4M58.9M53.5M56.1M
Change To Inventory(24.8M)(18.4M)(8.4M)(14.4M)4.4M4.7M
Net Borrowings(2.8M)94.7M(3.1M)(2.8M)(2.5M)(2.4M)
Change To Netincome9.4M33.3M21.5M5.7M6.6M6.3M
Investments(73.1M)5.7M(10.7M)(501K)(28.2M)(29.6M)

Artivion Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Artivion's current stock value. Our valuation model uses many indicators to compare Artivion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Artivion competition to find correlations between indicators driving Artivion's intrinsic value. More Info.
Artivion is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Artivion's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Artivion by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Artivion Systematic Risk

Artivion's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Artivion volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Artivion correlated with the market. If Beta is less than 0 Artivion generally moves in the opposite direction as compared to the market. If Artivion Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Artivion is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Artivion is generally in the same direction as the market. If Beta > 1 Artivion moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Artivion Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Artivion's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Artivion growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.63

At this time, Artivion's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Artivion March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Artivion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Artivion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Artivion based on widely used predictive technical indicators. In general, we focus on analyzing Artivion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Artivion's daily price indicators and compare them against related drivers.

Additional Tools for Artivion Stock Analysis

When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.